United States · What does Argenx invest in?
Argenx invests most often at Series B (100% of the rounds on record), in sectors such as Biotechnology, Clinical Trials and Therapeutics.
Argenx highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B: 100% of its rounds
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- BiotechnologyClinical TrialsTherapeutics
- Based in
- Boston, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2026
1 round
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
0 of 2 we have independently watched raise
VYVGARTVYVGART
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.